Funnelfeedr Logo

Abarceo Pharma AB

Sverige559139-7160Active

Developing novel small molecule therapeutics targeting VDAC1 for diabetes.

Biotechnology Companyabarceo.com

Oversigt

5–9
Medarbejdere
2.5–5mio SEK
Omsætning
2017
Grundlagt

Nøglebeslutningstagere

Mozhgan Dorkhan

Consulting CMO

Adam Bruce

CEO

Claes Post

Board Member

Claes Wollheim

CSO & Scientific Founder, Board Member

+11 flere kontakter i Funnelfeedr

Beskrivelse

Abarceo Pharma is a pre-clinical stage biotechnology company founded in 2017 as a spin-out from the Lund University Diabetes Center. It was established by world-renowned scientists specializing in diabetes research and beta-cell biology. The company has identified Voltage-Dependent Anion Channel 1 (...

Tags

B2BHealthcarePharmaceuticalsProfessional ServicesWhite Collar

Nøgleord

BiotechDiabetes TherapeuticsDrug DiscoveryMitochondrial DysfunctionType 2 DiabetesVDAC1 Target

Teknologistak

jQuery MigratejQueryBootstrapPriority HintsWordPressVarnishApache HTTP ServerPHPMagnific PopupFitVids.JSEasy Pie ChartYouTubejQuery Mobile

Virksomhedsoplysninger

Branche
Bioteknisk forskning och utveckling
Juridisk form
Aktiebolag
Momsnummer
SE559139716001

Beslutningstagere

15 kontakter i Funnelfeedr

Mozhgan Dorkhan

Consulting CMO

Adam Bruce

CEO

Claes Post

Board Member

Claes Wollheim

CSO & Scientific Founder, Board Member

Per Aniansson

Chairman of the Board

Ulrich Koch

Independent Board Member

William Dalby Brown

Head of Medicinal Chemistry and Screening

Henrik Otendal

CFO

Tara Heitner

Vice Chair

Albert Salehi

Scientific Founder

Jan Alenfall

COO

Andre kontakter

Steven Kahn

Scientific Advisor

Michael Karin

Scientific Advisor

Kent Bodensgaard

Scientific Advisor

Ruchi Jain

Principal Scientist

Lignende virksomheder

20 lignende virksomheder i Funnelfeedr

Udforsk mere

Spørgsmål om Abarceo Pharma AB

Vil du se Funnelfeedr i aktion?

Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.

Book en demo